£243.99

Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (Pharmacology Research Safety T) (Pharmacology - Research, Safety Testing and Regulation)

Other Branches of Medicine

Price data last checked 21 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£244 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days · 70 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 70 days • 1 price levels

Days at Price

Price Analysis

Most common price: £244 (70 days, 100.0%)

Price range: £244 - £244

Price levels: 1 different prices over 70 days

Description

In the late 1950s, Sir James Black made a tremendous contribution to pharmacology and medicine with his discovery of β-blockers. After the first β-blockers became available in the 1960s, these drugs were noted to have beneficial effects in reducing morbidity and mortality from ischemic heart disease. It soon thereafter became apparent that blocking the adverse effects of the sympathetic nervous system could benefit many other diseases. As research and development continued, later generations of β-blockers appeared, each with unique properties such that it is now impossible to group these agents into one class to uniformly describe their effects. In this edition of Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications, the authors examine how β-blockers have evolved from their origin as a treatment for angina to a myriad of other related and unrelated medical conditions. These include (in order of appearance), heart failure, hypertension, sepsis, tachydysrhythmias, portal hypertension, variceal bleeding, stimulant toxicity, thyrotoxicosis, obstructive lung disease, trauma, pheochromocytoma, cancer, acute coronary syndromes, and coronary arterial disease. The authors of these chapters hail from a spectrum of medical specialties as diverse as the indications for β-blockers: anesthesiology, cardiology, critical care, emergency medicine, gastroenterology, hematology/oncology, internal medicine, pharmacology, pulmonology, surgery, and toxicology. In this book, we also discuss controversies as well as the evolving and changing indications and contraindications for the use of this amazing class of drugs. This book will be of interest to physicians, pharmacists, nurse practitioners, physician assistants, nurses, research scientists, and informed patients. About the Author John R. Richards, M.D. (Department of Emergency Medicine, University of California, Davis School of Medicine, Sacramento, California, USA)

Product Specifications

Format: hardcover
ASIN: 1536133116
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain: Amazon UK
Release Date: 01 April 2018
Listed Since: 12 April 2018

Barcode

No barcode data available

Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (Pharmacology Research Safety T) (Pharmacology - Research, Safety Testing and Regulation)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Amlodipine

The ESC Handbook on Cardiovascular Pharmacotherapy (The European Society of Cardiology Series)

Prof. of Drug Substances, Excipients and Related Methodology: Volume 46

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... in Cardiovascular Medicine, 100)

Principles of General and Autonomic Pharmacology

Springer Pharmacology of Antihypertensive Therapeutics Book

Elsevier Opie's Cardiovascular Drugs - 9th Edition Reference

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... in Cardiovascular Medicine, 100)

Clinical Applications of Cardiovascular Drugs: 5 (Developments in Cardiovascular Medicine, 5)

Beta-Rezeptorenblocker: Aktuelle klinische Pharmakologie und Therapie

ACE Inhibitors (Milestones in Drug Therapy)

Autonome Innervation des Herzens Myokardiale Hypoxie

Cardiovascular Drug Therapy in the Elderly: 72 (Developments in Cardiovascular Medicine)

Cardiovascular Drug Therapy in the Elderly: 72 (Developments in Cardiovascular Medicine, 72)

MRCP Part 1: Targeted SBAs to help you pass first time: Cardiology, Clinical Pharmacology and Endocrinology

Treatment with Gallopamil: Results of recent research on calcium antagonism

Antiarrhythmic Drugs (Current Cardiovascular Therapy)

Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment (Updates in Hypertension and Cardiovascular Protection)

Cardiovascular Pharmacotherapeutics: Abridged and Updated

Pharmacological Aspects of Heart Disease: Proceedings of an International Symposium on Heart Metabolism in Health and Disease and the Third Annual ... (Developments in Cardiovascular Medicine, 68)

Antihypertensive Agents: 39 (Handbook of Experimental Pharmacology, 39)

Routledge Ashgate Handbook of Cardiovascular Agents Guide

Routledge Quick Reference to Cardiovascular Pharmacotherapy

Cardiovascular Pharmacology: Endothelial Control: 60 (Advances in Pharmacology): Volume 60